Proteometabolomics of bladder cancer: current and future prospects

Cancer Biomarkers : Section a of Disease Markers
Navneeta BansalSatya Narain Sankhwar

Abstract

Urinary bladder cancer (BC) is fifth most common cancer worldwide; the diagnostic methods are mostly instrumental approaches including cystoscopy and cytology. Since BC recurrence rate is high, consequently requires long-term follow-up. The molecular assays that can precisely identify BC at an early stage are obligatory. Although several noninvasive urine and blood samples based biomarkers have been proposed in the last decade but only few have been approved by Food and drug administration (FDA) for clinical purpose. Hence the search for more suitable biomarker is still on. In this review, we summarize the urine and blood based metabolic and protein tests not only for determination but also BC patient surveillance.

Citations

Feb 29, 2016·Journal of Pharmaceutical and Biomedical Analysis·Navneeta BansalAbbas Ali Mahdi
Feb 19, 2019·Expert Review of Proteomics·Chandra Sekhar AmaraNagireddy Putluri
Dec 7, 2018·Biomarkers in Medicine·Wen-Tao ZhangXu-Dong Yao
Nov 11, 2019·Journal of Pharmaceutical and Biomedical Analysis·Malena ManziMaría Eugenia Monge

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.